PHARNEXT
Developing therapeutics for neurodegenerative diseases
- B2B
About PHARNEXT
A clinical-stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases, with two lead products in clinical development for CMT1A and Alzheimer's disease
Key facts
- Industry
- Biotechnology Research
- Company size
- 11–50 employees
- Headquarters
- suresnes, Île-de-France, France
- Founded
- 2007
- Revenue
- $4.9M – $38.8MTamtam estimate
- Website
- pharnext.com
- linkedin.com/company/pharnext
PHARNEXT at a glance
PHARNEXT is a B2B company in the Biotechnology Research industry, headquartered in suresnes, Île-de-France, France.
PHARNEXT was founded in 2007.
PHARNEXT has 11–50 employees.
PHARNEXT's revenue is $4.9M – $38.8M (Tamtam estimate).
Selling to companies like PHARNEXT?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies